had news and 8k on the 5th so check them out first.
volume was picking up before news.

chart: weird but...
http://stockcharts.com/def/servlet/SC.web?c=etpt,uu[m,a]daclyyay[pb50!b200][vc60][iUb14!La12,26,9]&pref=G

ETPT - ENTERPRISE TECHS (OTCBB)
Date Open High Low Last Change Volume % Change
08/06/04 0.4900 0.6200 0.4600 0.4600 +0.0600 137800 +15.00%

Composite Indicator
Trend Spotter TM Hold

Short Term Indicators
7 Day Average Directional Indicator Buy
10 - 8 Day Moving Average Hilo Channel Buy
20 Day Moving Average vs Price Buy
20 - 50 Day MACD Oscillator Sell
20 Day Bollinger Bands Buy

Short Term Indicators Average: 60% - Buy
20-Day Average Volume - 29190

Medium Term Indicators
40 Day Commodity Channel Index Buy
50 Day Moving Average vs Price Buy
20 - 100 Day MACD Oscillator Sell
50 Day Parabolic Time/Price Buy

Medium Term Indicators Average: 50% - Buy
50-Day Average Volume - 23462

Long Term Indicators
60 Day Commodity Channel Index Buy
100 Day Moving Average vs Price Buy
50 - 100 Day MACD Oscillator Buy

Long Term Indicators Average: 100% - Buy
100-Day Average Volume - 21169

Overall Average: 64% - Buy

Price Support Pivot Point Resistance

0.4600 0.3533 0.5133 0.6733

8k summary:

http://biz.yahoo.com/e/040805/etpt.ob8-k.html

news:Enterprise Enters into License Agreement with New York University
Thursday August 5, 6:30 am ET

VANCOUVER, British Columbia--(BUSINESS WIRE)--Aug. 5, 2004--Enterprise Technologies, Inc. (OTCBB:ETPT - News), is pleased to announce that its wholly owned subsidiary, Phytomedical Technologies Corporation (Phytomedical), has entered into an exclusive worldwide licensing agreement with New York University (NYU) for certain patented inventions ("NYU Patents") related to pharmacologically active elements of a muira puama plant extract and ion channel modulators from natural sources.
ADVERTISEMENT


Presently, a quarter of all prescription drugs contain active compounds originally found in or patterned after compounds derived from natural sources. In fact, twenty of the best selling drugs come from plants, including the antibiotic erythromycin, the immunosuppressive cyclosporin-A, the anti-cholesterol drug lovastatin and the anti-tumor agent paclitaxel (Taxol), discovered from the Pacific Yew tree, which alone has generated over $10 billion in sales since 1993.

Of the 250,000 species of higher plants found on earth, of which approximately 155,000 are found in tropical rainforests, less than 15% have been investigated for bioactive compounds. From these plants, an estimated 300 new drugs of world-wide importance, worth over $150 billion, still remain to be discovered.

Named BDC 03, the first plant derived compound to be developed by Phytomedical, has pharmacologically active elements that have been successful in reducing body fat percentage, increasing lean muscle mass and lowering cholesterol in animal studies.

The same compound, BDC 03, administered over a three month period to a healthy 45 year old male subject, resulted in a 5% reduction in body fat and a 15 pound gain in muscle mass, indicating that the additional weight had been preferentially shifted toward lean muscle -- with no appreciable change in diet or exercise.

Additionally, the male subject did not experience any alterations in facial or body hair, exacerbation of acne or alterations in liver function tests, which are androgenic symptoms commonly experienced after treatment with anabolic steroids.

For obese or overweight individuals, BDC 03's potential capacity to decrease the deposition of fat and lower cholesterol is a vitally important therapeutic outcome. However, its prospective ability to induce overall weight gain in the form of lean muscle mass may well be the difference between life and death for individuals suffering from cachexia.

Cachexia, which is characterized by dramatic weight loss, not only of fatty tissue, but also muscle tissue and bone, is among the most devastating and life-threatening aspects of AIDS and cancer. Once the body loses 30% of its lean muscle mass, major organs are affected, resulting in death.

Sadly, cachexia afflicts 25% of all AIDS patients and upwards of 90% of all advanced cancer patients. In fact, half of all cancer related deaths are a result of cachexia, not the cancer itself